Article Details
Retrieved on: 2021-06-03 21:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Since 2017, Pfizer's kinase inhibitor Sutent has been approved to help prevent tumors from returning in high-risk kidney cancer patients after surgery.
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here